Profoundly incompetent management - Mitarbeiter (anonym) bei Bio-Techne: Mitarbeiterbewertung

1.0
15. Sept. 2025
Mitarbeiter (anonym)
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

People outside of management seem decent.

Kontras

Let's let facts speak for themselves- Bio-techne bought a company for $275Million in 2018. Somehow they managed to drive that company into the ground- selling it for a whopping $15Million due to close this month! Buy high, sell low. I'd be pissed if I was an investor... Stay far away- this company's leaderhship has absolutely no idea how to run a business. Toxic place, so grateful to be out of that shit-show.

Mehr Bewertungen zu Bio-Techne entdecken

5.0
6. Mai 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Great benefits, solid work life balance, great training and resources

Kontras

Constant reorganization and very little transparency from Senior Management.

5.0
30. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Good benefits, people and hybrid schedule

Kontras

Restructuring has it made thing challenging for the businesses

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle